Overall, these data suggested that loss of FoxP1 may contribute to the development of chronic lung diseases because variants in the FoxP1 gene that were associated with higher mRNA levels were also associated with improved lung function and reduced odds of a diagnosis of IPF. This evidence concerns the gene FOXP1 and chronic lung disease.